Contact Us

Shop Details

Product Image

Rs.3,985.25

Romy 250 (Romiplostim 250mcg)

(3 customer reviews)

Romy 250 is a trusted pharmaceutical product developed by Intas, containing the active ingredient Romiplostim. This medication is used in the treatment of thrombocytopenia (low platelet count) associated with chronic immune thrombocytopenia (ITP), helping to boost platelet production and reduce the risk of bleeding. With a proven track record for safety and efficacy, Romy 250 plays a critical role in improving the quality of life for patients with ITP.

Availability: In Stock

Brand: Intas Composition: Romiplostim 250mcg

Product Introduction

Chronic immune thrombocytopenia (ITP) is a condition characterized by low platelet counts, leading to an increased risk of bleeding and bruising. Romy 250 (Romiplostim 250mcg) offers an effective solution for managing ITP by stimulating the production of platelets in the bone marrow, thus improving platelet counts and reducing bleeding episodes. This treatment has shown positive results in enhancing patients' quality of life.

Designed for patients suffering from chronic ITP, Romy 250 is administered through subcutaneous injection and can be adjusted based on individual response. This medication not only helps in reducing the need for platelet transfusions but also minimizes the risk of life-threatening bleeding associated with the condition.

Uses of Romy 250 (Romiplostim 250mcg)

Romy 250 is primarily indicated for:

service
  • Chronic Immune Thrombocytopenia (ITP) – Used to increase platelet count and reduce bleeding risk in ITP patients.
  • Reduction of Bleeding Episodes – Helps reduce the frequency of bleeding associated with ITP.
  • Platelet Transfusion Minimization – Reduces the need for platelet transfusions.

Romy 250 helps in effectively managing ITP by stimulating platelet production in the bone marrow, offering a viable treatment option for patients facing chronic platelet deficiency.

Side Effects of Romy 250 (Romiplostim 250mcg)

Like any medication, Romy 250 may cause side effects. While many patients tolerate it well, some may experience the following:

  • Headache
  • Nausea
  • Fatigue
  • Joint pain
  • Dizziness

Less Common Side Effects

Less common side effects of Romy 250 (Romiplostim 250mcg) may include:

  • Thrombotic events (blood clots)
  • Increased liver enzymes
  • Allergic reactions

We are pleased to offer you a solution for platelet deficiency.

Romy 250 provides an advanced treatment for chronic ITP patients, offering hope for managing platelet levels and reducing the risk of serious bleeding complications. Romy 250 is a breakthrough in hematology, and with proper monitoring, it can provide long-term benefits for patients.

  • The standard dosage is one injection (250mcg) administered weekly.
  • The dosage can be adjusted based on platelet response.
  • Injection is given subcutaneously, typically in the thigh or abdomen area.
  • The treatment duration is determined by the patient’s response to the medication.
  • Regular monitoring of platelet count and blood tests are recommended during treatment.

Romy 250 works by stimulating the thrombopoietin receptor in the bone marrow, which leads to an increase in the production of platelets. These platelets help reduce the risk of bleeding and bruising in patients with chronic ITP. By mimicking the action of a natural protein, Romy 250 supports platelet regeneration and boosts the body’s ability to fight bleeding complications.

  • Proven to increase platelet counts and reduce bleeding episodes in ITP patients.
  • Reduces the need for platelet transfusions.
  • Minimizes bleeding complications associated with low platelet counts.
  • Convenient subcutaneous weekly injection.
  • Romy 250 should be used with caution in patients with a history of blood clots.
  • Monitor for any signs of allergic reactions.
  • Regular blood tests are essential to monitor platelet levels and liver function.